Xenotransplantation: Promises and Perils.
Publication
, Journal Article
Ladowski, JM; Bazzi, N; Kirk, AD
Published in: Annu Rev Med
October 8, 2025
Xenotransplantation of genetically modified pig organs has the potential to change the landscape of transplantation and chronic disease management by providing limitless personalized organs on demand. Decades of progress have resulted in recent US Food and Drug Administration approval for human clinical trials. Understandably, hope for the field is at a maximum, fueled by exciting anecdotal experiences, each providing new insights and questions. While further work is needed before widespread clinical application is plausible, the promise of xenotransplantation has never been more evident. In this review, we seek to highlight recent progress, suggest remaining research questions, and touch on the future of the field.
Duke Scholars
Published In
Annu Rev Med
DOI
EISSN
1545-326X
Publication Date
October 8, 2025
Location
United States
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ladowski, J. M., Bazzi, N., & Kirk, A. D. (2025). Xenotransplantation: Promises and Perils. Annu Rev Med. https://doi.org/10.1146/annurev-med-043024-015252
Ladowski, Joseph M., Nagham Bazzi, and Allan D. Kirk. “Xenotransplantation: Promises and Perils.” Annu Rev Med, October 8, 2025. https://doi.org/10.1146/annurev-med-043024-015252.
Ladowski JM, Bazzi N, Kirk AD. Xenotransplantation: Promises and Perils. Annu Rev Med. 2025 Oct 8;
Ladowski, Joseph M., et al. “Xenotransplantation: Promises and Perils.” Annu Rev Med, Oct. 2025. Pubmed, doi:10.1146/annurev-med-043024-015252.
Ladowski JM, Bazzi N, Kirk AD. Xenotransplantation: Promises and Perils. Annu Rev Med. 2025 Oct 8;
Published In
Annu Rev Med
DOI
EISSN
1545-326X
Publication Date
October 8, 2025
Location
United States
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences